Bousquet Paula A, Sandvik Joe Alexander, Arntzen Magnus Ø, Jeppesen Edin Nina F, Christoffersen Stine, Krengel Ute, Pettersen Erik O, Thiede Bernd
Department of Chemistry, University of Oslo, P.O. Box 1033 Blindern, 0315 Oslo, Norway.
Department of Physics, University of Oslo, P.O. Box 1048 Blindern, 0315 Oslo, Norway.
Int J Proteomics. 2015;2015:678527. doi: 10.1155/2015/678527. Epub 2015 Sep 2.
Hypoxia is an important and common characteristic of many human tumors. It is a challenge clinically due to the correlation with poor prognosis and resistance to radiation and chemotherapy. Understanding the biochemical response to hypoxia would facilitate the development of novel therapeutics for cancer treatment. Here, we investigate alterations in gene expression in response to hypoxia by quantitative proteome analysis using stable isotope labeling with amino acids in cell culture (SILAC) in conjunction with LCMS/MS. Human HeLa cells were kept either in a hypoxic environment or under normoxic conditions. 125 proteins were found to be regulated, with maximum alteration of 18-fold. In particular, three clusters of differentially regulated proteins were identified, showing significant upregulation of glycolysis and downregulation of mitochondrial ribosomal proteins and translocases. This interaction is likely orchestrated by HIF-1. We also investigated the effect of hypoxia on the cell cycle, which shows accumulation in G1 and a prolonged S phase under these conditions. Implications. This work not only improves our understanding of the response to hypoxia, but also reveals proteins important for malignant progression, which may be targeted in future therapies.
缺氧是许多人类肿瘤的一个重要且常见的特征。由于其与预后不良以及对放疗和化疗的抗性相关,它在临床上是一个挑战。了解对缺氧的生化反应将有助于开发用于癌症治疗的新型疗法。在此,我们通过使用细胞培养中氨基酸稳定同位素标记(SILAC)结合液相色谱-质谱联用(LCMS/MS)的定量蛋白质组分析来研究缺氧反应中基因表达的变化。将人宫颈癌细胞系HeLa细胞置于缺氧环境或常氧条件下。发现有125种蛋白质受到调控,最大变化为18倍。特别地,鉴定出三组差异调节的蛋白质,显示糖酵解显著上调,线粒体核糖体蛋白和转位酶下调。这种相互作用可能由缺氧诱导因子-1(HIF-1)协调。我们还研究了缺氧对细胞周期的影响,结果显示在这些条件下细胞在G1期积累且S期延长。意义。这项工作不仅增进了我们对缺氧反应的理解,还揭示了对恶性进展重要的蛋白质,这些蛋白质可能成为未来治疗的靶点。